BSE filing, NSE: ISLCONSUL. Summary written from the filing by ALFA Finder's alert engine.
ISL Consulting Ltd: key numbers
- Share price
- ₹11.00
- Market cap
- ₹26.40 Cr
- Revenue (annual)
- ₹18.64 Cr
- Net profit (annual)
- ₹-2.04 Cr
- P/E (TTM)
- -80.9×Sector 19.7×
- Promoter holding
- 60.06%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ISL Consulting Ltd
All →ISL Consulting Board Meeting Date
ISL Consulting Ltd scheduled a board meeting for November 4, 2026. The agenda covers approval of Q1 and H1 FY27 standalone results and related party transactions.
ISL Consulting Other Announcement
ISL Consulting Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory filings.
ISL Consulting Management Change
ISL Consulting Limited has appointed M/s. G M C A & CO. as Statutory Auditors for a five-year term. The appointment is effective from August 31, 2026.
- Execution
- 60 months
ISL Consulting Other Announcement
ISL Consulting Limited has appointed M/s G M C A & CO. as Statutory Auditors for a five-year term. The appointment was approved by shareholders at the Annual General Meeting.
- Execution
- 5 years
ISL Consulting Annual General Meeting
ISL Consulting Limited held its 34th Annual General Meeting on September 29, 2026. Shareholders considered the adoption of audited financial statements, director re-appointment, and statutory auditor appointment.
ISL Consulting Annual Report
ISL Consulting filed its 34th Annual Report for FY 2025-26 under Regulation 34. The filing also encloses the notice for the 34th AGM on 29 September 2026.
Other board meeting date announcements
All →Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.